Next Article in Journal
Adult Stem Cell Therapeutics in Diabetic Retinopathy
Next Article in Special Issue
Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behçet’s Disease with Arthritis
Previous Article in Journal
Characterization and Establishment of an Immortalized Rabbit Melanocyte Cell Line Using the SV40 Large T Antigen
Previous Article in Special Issue
The Role of Major Histocompatibility Complex in Organ Transplantation- Donor Specific Anti-Major Histocompatibility Complex Antibodies Analysis Goes to the Next Stage -
Open AccessArticle

Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34+ Cell Viability after Thawing

1
Specialized researcher, Cord Blood Bank, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud. Cra. 32 # 12-81, Bogotá 111611, Colombia
2
Director, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud. Cra. 32 # 12-81, Bogotá 111611, Colombia
3
Scientific leader, Cord Blood Bank, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud. Cra. 32 # 12-81, Bogotá 111611, Colombia
*
Author to whom correspondence should be addressed.
Current address: Montreal Clinical Research Institute, Molecular Oncology Unit, 110 Pine Ave W, Montreal, QC H2W1R7, Canada.
Current address: Advanced Therapies Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud. Cra. 32 # 12-81, 111611 Bogotá, Colombia.
Int. J. Mol. Sci. 2019, 20(19), 4875; https://doi.org/10.3390/ijms20194875
Received: 29 August 2019 / Revised: 21 September 2019 / Accepted: 25 September 2019 / Published: 30 September 2019
(This article belongs to the Special Issue Major Histocompatibility Complex (MHC))
Hematopoietic progenitor cell (HPC) transplantation is a treatment option for malignant and nonmalignant diseases. Umbilical cord blood (UCB) is an important HPC source, mainly for pediatric patients. It has been demonstrated that human leukocyte antigen (HLA) matching and cell dose are the most important features impacting clinical outcomes. However, UCB matching is performed using low resolution HLA typing and it has been demonstrated that the unnoticed mismatches negatively impact the transplant. Since we found differences in CD34+ viability after thawing of UCB units matched for two different patients (p = 0.05), we presumed a possible association between CD34+ cell viability and HLA. We performed a multivariate linear model (n = 67), comprising pre-cryopreservation variables and high resolution HLA genotypes separately. We found that pre-cryopreservation red blood cells (RBC), granulocytes, and viable CD34+ cell count significantly impacted CD34+ viability after thawing, along with HLA-B or -C (R2 = 0.95, p = 0.01; R2 = 0.56, p = 0.007, respectively). Although HLA-B*40:02 may have a negative impact on CD34+ cell viability, RBC depletion significantly improves it. View Full-Text
Keywords: umbilical cord blood; hematopoietic stem cell transplantation; human leukocyte antigen; cell viability; thawing umbilical cord blood; hematopoietic stem cell transplantation; human leukocyte antigen; cell viability; thawing
Show Figures

Figure 1

MDPI and ACS Style

Vanegas, D.; Galindo, C.-C.; Páez-Gutiérrez, I.-A.; González-Acero, L.-X.; Medina-Valderrama, P.-T.; Lozano, J.-C.; Camacho-Rodríguez, B.; Perdomo-Arciniegas, A.-M. Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34+ Cell Viability after Thawing. Int. J. Mol. Sci. 2019, 20, 4875.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop